Medifast, Inc.MEDNYSE
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-46.8%
5Y CAGR-45.0%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-46.8%/yr
vs -27.7%/yr prior
5Y CAGR
-45.0%/yr
Consistent
Acceleration
-19.0pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
5 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.12-40.7%
20240.20-68.2%
20230.61-20.1%
20220.77-50.7%
20211.56-32.5%
20202.31+34.4%
20191.72-39.0%
20182.82+12.2%
20172.51+56.2%
20161.61-